MacroGenics, Inc. MGNX
2.15 USD -0.06 (-2.50%)
As ofNov 16, 2026, 3:49 PM EST
1.93 Day range 2.24
1.33 52-week range 4.86
- YTD
- +33.23%
- 1 year
- +43.00%
Benzinga news
benzinga.com Macrogenics Q3 EPS $(0.34) Misses $(0.12) Estimate, Sales $18.667M Miss $43.748M Estimate Macrogenics (NASDAQ:MGNX) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.12) by 183.33 percent. This is a 342.86 percent decrease over earnings of…
benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session Gainers Bolt Biotherapeutics (NASDAQ:BOLT) shares moved upwards by 58.8% to $6.65 during Friday's regular session. The market value of their outstanding shares is at $7.9 million. Lucid Diagnostics…benzinga.com MacroGenics Announces Phase 1 MGC026 Delivers 27% Response Rate In SCCHN, Showing Durable Tumor Activity And Advancing Toward Front-Line Pembrolizumab Combination Trial Durable responses observed across multiple tumor types during dose escalationMGC026 demonstrated 27% best overall response rate (6/22 patients; 4 confirmed and 2 unconfirmed PRs) in heavily…
